Eyal Attar

No más puestos en curso

55 años

Health Technology

Consumer Services

Perfil

Eyal C.
Attar formerly worked at Agios Pharmaceuticals, Inc., as Senior Medical Director from 2016 to 2019, Harvard Medical School, as Member-Leukemia Center, Aprea Therapeutics, Inc., as Chief Medical Officer & Senior Vice President, and Vor Biopharma, Inc., as Chief Medical Officer from 2022 to 2025.
Dr. Attar received his doctorate degree from UNC School of Medicine.

Antiguos cargos conocidos de Eyal Attar.

Empresas	Cargo	Fin
VOR BIOPHARMA INC.	Director Técnico/Científico/I+D	18/04/2025
AGIOS PHARMACEUTICALS, INC.	Director Técnico/Científico/I+D	01/01/2019
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
APREA THERAPEUTICS, INC.	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de Eyal Attar.

Formación de Eyal Attar.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Eyal Attar.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	5
Agios Pharmaceuticals, Inc. Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
UNC School of Medicine UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vor Biopharma, Inc. Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies	Health Technology
Aprea Therapeutics, Inc. Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds	Health Technology